pembrolizumab
merck
['breast', 'pembro', 'bcsm']
oral abstract session at #asco22 on early #breastcancer: more data from #keynote522 trial showing results according to #rcb score...very poor outcomes and apparently no benefit from #pembrolizumab in the rcb3 group (urgent intervention needed in these patients) #bcsm 
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Prior @myESMO fellow. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.